title: Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain.
abstract: In the pilocarpine model of temporal lobe epilepsy, mossy fibers coexpress the inhibitory transmitter neuropeptide Y (NPY) with glutamate. The effects of endogenous and applied NPY on recurrent mossy fiber synaptic transmission were investigated with the use of whole-cell voltage-clamp and field recordings in rat hippocampal slices. Applied NPY reversibly inhibited synaptic transmission at recurrent mossy fiber synapses on dentate granule cells but not at perforant path or associational-commissural synapses. It also reduced the frequency of miniature EPSCs (mEPSCs) in granule cells from epileptic, but not control, rats and depressed granule cell epileptiform activity dependent on the recurrent mossy fiber pathway. These actions of NPY were mediated by activation of presynaptic Y2 receptors. The Y2 receptor antagonist (S)-N2-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6H)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]argininamide (BIIE0246) not only blocked the effects of NPY but also enhanced recurrent mossy fiber synaptic transmission, the frequency of mEPSCs, and the magnitude of mossy fiber-evoked granule cell epileptiform activity when applied by itself. Several observations supported the selectivity of BIIE0246. These results suggest that even the spontaneous release of NPY (or an active metabolite) from recurrent mossy fibers is sufficient to depress glutamate release from this pathway. Tonic release of NPY accounts at least partially for the low probability of glutamate release from recurrent mossy fiber terminals, impedes the ability of these fibers to synchronize granule cell discharge, and may protect the hippocampus from seizures that involve the entorhinal cortex. This pathway may synchronize granule cell discharge more effectively in human brain than in rat because of its lower expression of NPY.
authors.affiliation: Department of Pharmacology and Cancer Biolog, Duke University Medical Center, Durham, North Carolina 27710, USA.
authors.forename: Bin
authors.initials: B
authors.lastname: Tu
authors.forename: Olga
authors.initials: O
authors.lastname: Timofeeva
authors.forename: Yiqun
authors.initials: Y
authors.lastname: Jiao
authors.forename: J Victor
authors.initials: JV
authors.lastname: Nadler
mesh_terms: D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology; D001640:Bicuculline / Q000494:pharmacology; D003292:Convulsants / Q000633:toxicity; D018891:Dentate Gyrus / Q000737:chemistry / Q000648:ultrastructure; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D006624:Hippocampus / Q000737:chemistry / Q000503:physiopathology* / Q000648:ultrastructure; D008297:Male; D019599:Mossy Fibers, Hippocampal / Q000378:metabolism* / Q000503:physiopathology; D009478:Neuropeptide Y / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D019580:Perforant Pathway / Q000187:drug effects; D010862:Pilocarpine / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000502:physiology; D017476:Receptors, Neuropeptide Y / Q000037:antagonists & inhibitors / Q000502:physiology; D013226:Status Epilepticus / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D009435:Synaptic Transmission / Q000502:physiology*; D013779:Tetrodotoxin / Q000494:pharmacology
chemical_list: D001552:Benzazepines; D003292:Convulsants; D009478:Neuropeptide Y; D016194:Receptors, N-Methyl-D-Aspartate; D017476:Receptors, Neuropeptide Y; C095889:neuropeptide Y2 receptor; D010862:Pilocarpine; D013779:Tetrodotoxin; D015763:2-Amino-5-phosphonovalerate; D001120:Arginine; C403256:BIIE 0246; D001640:Bicuculline
references.citation: Trends Neurosci. 1999 Jan;22(1):25-30
references.pmid: 10088996
references.citation: J Neurophysiol. 1999 Apr;81(4):1645-60
references.pmid: 10200201
references.citation: Neuroscience. 1999;90(4):1445-61
references.pmid: 10338311
references.citation: J Neurophysiol. 1999 Jul;82(1):478-83
references.pmid: 10400974
references.citation: Epilepsy Res. 1999 Aug;36(1):31-42
references.pmid: 10463848
references.citation: Exp Neurol. 1999 Sep;159(1):73-83
references.pmid: 10486176
references.citation: J Neurophysiol. 1999 Oct;82(4):1883-94
references.pmid: 10515977
references.citation: Eur J Pharmacol. 1999 Nov 19;384(2-3):R3-5
references.pmid: 10611450
references.citation: Brain Res. 1999 Nov 27;848(1-2):153-66
references.pmid: 10612707
references.citation: Br J Pharmacol. 2000 Mar;129(6):1075-88
references.pmid: 10725255
references.citation: J Neurosci. 2000 Aug 15;20(16):6144-58
references.pmid: 10934264
references.citation: Eur J Pharmacol. 2000 Sep 15;404(1-2):133-6
references.pmid: 10980271
references.citation: J Neurophysiol. 2000 Nov;84(5):2380-9
references.pmid: 11067980
references.citation: J Physiol. 2001 Feb 15;531(Pt 1):81-94
references.pmid: 11179393
references.citation: Eur J Neurosci. 2001 Feb;13(4):657-69
references.pmid: 11207801
references.citation: J Neurosci. 2001 Aug 1;21(15):5804-12
references.pmid: 11466452
references.citation: Brain Res. 2001 Oct 5;915(1):58-69
references.pmid: 11578620
references.citation: J Neurophysiol. 2002 Jan;87(1):558-66
references.pmid: 11784771
references.citation: Br J Pharmacol. 2002 Jun;136(4):502-9
references.pmid: 12055128
references.citation: J Neurosci. 2002 Jul 15;22(14):6052-61
references.pmid: 12122066
references.citation: J Comp Neurol. 2003 Apr 21;459(1):44-76
references.pmid: 12629666
references.citation: J Neurosci. 2003 Jun 15;23(12):5381-90
references.pmid: 12832564
references.citation: Epilepsy Res Suppl. 1992;7:301-13
references.pmid: 1334669
references.citation: J Neurophysiol. 2003 Oct;90(4):2536-47
references.pmid: 14534276
references.citation: J Neurosci. 2003 Oct 22;23(29):9639-49
references.pmid: 14573544
references.citation: Neurochem Res. 2003 Nov;28(11):1649-58
references.pmid: 14584819
references.citation: Epilepsy Res Suppl. 1992;7:223-34
references.pmid: 1466768
references.citation: Brain Res. 1992 Feb 28;573(2):305-10
references.pmid: 1504768
references.citation: Epilepsy Curr. 2003 Mar;3(2):53-58
references.pmid: 15309085
references.citation: Neuropeptides. 2004 Aug;38(4):245-52
references.pmid: 15337376
references.citation: J Neurosci. 2004 Oct 6;24(40):8741-51
references.pmid: 15470140
references.citation: Brain Res. 1992 May 1;579(1):119-27
references.pmid: 1623399
references.citation: Br J Pharmacol. 1991 Jan;102(1):41-4
references.pmid: 1646061
references.citation: Neuroscience. 1991;42(2):351-63
references.pmid: 1716744
references.citation: Ann Neurol. 1989 Sep;26(3):321-30
references.pmid: 2508534
references.citation: Neurosci Lett. 1989 May 8;99(3):351-5
references.pmid: 2542848
references.citation: Brain Res. 1989 Aug 28;495(2):387-95
references.pmid: 2569920
references.citation: J Neurosci Methods. 1989 Dec;30(3):203-10
references.pmid: 2607782
references.citation: J Neurophysiol. 1989 Jul;62(1):126-35
references.pmid: 2754466
references.citation: J Physiol. 1987 Feb;383:285-99
references.pmid: 2821236
references.citation: J Neurosci. 1988 Oct;8(10):3827-37
references.pmid: 2848110
references.citation: J Physiol. 1986 Nov;380:175-89
references.pmid: 2886653
references.citation: J Neurosci. 1985 Apr;5(4):1016-22
references.pmid: 3981241
references.citation: Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
references.pmid: 4110397
references.citation: Brain Res. 1983 Nov 28;280(1):25-40
references.pmid: 6652478
references.citation: Histochemistry. 1981;71(1):1-16
references.pmid: 6785259
references.citation: Epilepsia. 1995 Jun;36(6):543-58
references.pmid: 7555966
references.citation: Epilepsia. 1993 Nov-Dec;34(6):985-95
references.pmid: 7694849
references.citation: J Comp Neurol. 1995 Feb 20;352(4):515-34
references.pmid: 7721998
references.citation: J Neurosci. 1995 May;15(5 Pt 2):3990-4004
references.pmid: 7751960
references.citation: Br J Pharmacol. 1994 Nov;113(3):737-40
references.pmid: 7858862
references.citation: Hippocampus. 1993 Jan;3(1):103-11
references.pmid: 8395947
references.citation: Neuroscience. 1995 Dec;69(3):831-45
references.pmid: 8596652
references.citation: J Neurosci. 1996 Jul 15;16(14):4438-48
references.pmid: 8699254
references.citation: J Neurosci. 1996 Sep 15;16(18):5883-95
references.pmid: 8795640
references.citation: Regul Pept. 1996 Aug 27;65(1):71-7
references.pmid: 8876038
references.citation: Hippocampus. 1996;6(4):347-470
references.pmid: 8915675
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13304-9
references.pmid: 8917586
references.citation: J Neurophysiol. 1996 Nov;76(5):3159-68
references.pmid: 8930263
references.citation: Regul Pept. 1996 Nov 14;67(1):33-7
references.pmid: 8952003
references.citation: J Pharmacol Exp Ther. 1997 Apr;281(1):291-6
references.pmid: 9103509
references.citation: J Neurophysiol. 1997 May;77(5):2685-96
references.pmid: 9163384
references.citation: J Neurosci. 1997 Oct 1;17(19):7503-22
references.pmid: 9295396
references.citation: Epilepsy Res Suppl. 1996;12:137-44
references.pmid: 9302512
references.citation: Exp Brain Res. 1997 Aug;116(1):186-90
references.pmid: 9305828
references.citation: J Neurophysiol. 1997 Sep;78(3):1651-61
references.pmid: 9310450
references.citation: J Neurosci. 1997 Nov 1;17(21):8169-77
references.pmid: 9334392
references.citation: J Neurophysiol. 1998 Jan;79(1):418-29
references.pmid: 9425210
references.citation: Mol Pharmacol. 1998 Jan;53(1):6-13
references.pmid: 9443927
references.citation: J Neurochem. 1998 Apr;70(4):1615-22
references.pmid: 9523578
references.citation: J Neurochem. 1998 May;70(5):1950-63
references.pmid: 9572279
references.citation: Brain Res Brain Res Rev. 1998 May;26(2-3):154-66
references.pmid: 9651513